Skip Navigation


Carcinogenesis Advance Access originally published online on February 25, 2006
Carcinogenesis 2006 27(8):1655-1660; doi:10.1093/carcin/bgi374
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/8/1655    most recent
bgi374v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wirtenberger, M.
Right arrow Articles by Burwinkel, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wirtenberger, M.
Right arrow Articles by Burwinkel, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer

Michael Wirtenberger1,*, Bernd Frank1, Kari Hemminki1,2, Rüdiger Klaes3, Rita K. Schmutzler4, Barbara Wappenschmidt4, Alfons Meindl5, Marion Kiechle5, Norbert Arnold6, Bernhard H.F. Weber7, Dieter Niederacher8, Claus R. Bartram3 and Barbara Burwinkel1,9

1 Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 580, 69120, Heidelberg, Germany
2 Department of Biosciences at Novum, Karolinska Institute Huddinge, Sweden
3 Institute of Human Genetics, University of Heidelberg Heidelberg, Germany
4 Division of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, Center of Molecular Medicine Cologne (CMMC), University Hospital of Cologne Germany
5 Department of Gynaecology and obstetrics, Klinikum rechts der Isar at the Technical University Munich, Germany
6 Division of Oncology, Department of Gynaecology and Obstetrics, University Hospital Schleswig-Holstein Kiel, Germany
7 Institute of Human Genetics, University of Regensburg Regensburg, Germany
8 Division of Molecular Genetics, Department of Gynaecology and Obstetrics, Clinical Center University of Düsseldorf Düsseldorf, Germany
9 Helmholtz-university Group Molecular Epidemiology, German Cancer Research Center (DKFZ) Heidelberg, Germany

*To whom correspondence should be addressed. Tel: +49 6221 421811; Email: m.wirtenberger{at}dkfz.de

Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 MspI 1798G>A, which is completely linked to p53PIN3, a 16 bp insertion/duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys1367Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06–1.54) and high-risk familial breast cancer (OR = 1.32, 95% CI 1.06–1.65). The analysis of p53 MspI 1798G>A, which is completely linked to p53PIN3, showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.12–4.11). WRN Cys1367Arg, located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys1367Arg and p53 MspI resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19–9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
Z. Li, S. Lu, G. Hou, X. Ma, D. Sheng, J. Ni, and Y. Shen
Hjm/Hel308A DNA Helicase from Sulfolobus tokodaii Promotes Replication Fork Regression and Interacts with Hjc Endonuclease In Vitro
J. Bacteriol., April 15, 2008; 190(8): 3006 - 3017.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. S. Shanmugam, H. Brenner, M. Hoffmeister, J. Chang-Claude, and B. Burwinkel
The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk
Carcinogenesis, September 1, 2007; 28(9): 1914 - 1917.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. E. Mechanic, E. D. Bowman, J. A. Welsh, M. A. Khan, N. Hagiwara, L. Enewold, P. G. Shields, L. Burdette, S. Chanock, and C. C. Harris
Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 214 - 222.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, and C.-Y. Shen
Genetic Variation in the Premature Aging Gene WRN: A Case-Control Study on Breast Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 263 - 269.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.